Initial clinical experience of lorcainide (Ro 13-1042), a new antiarrhythmic agent
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 14 (2) , 105-109
- https://doi.org/10.1007/bf00607440
Abstract
Lorcainide is a promising antiarrhythmic agent that belongs to the class of local anesthetics. It was tested in 7 patients with malignant ventricular arrhythmias that were resistant to other antiarrhythmic agents. Lorcainide was effective in all cases (complete disappearance of arrhythmias in 6 cases and more than 50% disappearance in the 7th case), and the tolerance was within acceptable limits. The drug was effective at rest, as assessed by 24-h dynamic electrocardiographic monitoring, and during physical exercise. Longer studies with more patients are warranted, since the drug appears to be a promising antiarrhythmic agent.This publication has 6 references indexed in Scilit:
- IntroductionThe American Journal of Cardiology, 1977
- Quality of the ideal antiarrhythmic drugThe American Journal of Cardiology, 1977
- New concepts and approaches to sudden cardiac death.1976
- Ventricular TachyarrhythmiasCirculation, 1973
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971
- Aerobic work capacity in men and women with special reference to age.1960